このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

ICU Medical 将来の成長

Future 基準チェック /36

ICU Medical利益と収益がそれぞれ年間61.1%と2.5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に4.7% 61.2%なると予測されています。

主要情報

61.1%

収益成長率

62.1%

EPS成長率

Medical Equipment 収益成長	16.7%
収益成長率	2.5%
将来の株主資本利益率	4.7%
アナリストカバレッジ	Good
最終更新日	21 Jun 2024

今後の成長に関する最新情報

Recent updates

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 23

Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts

Jan 28

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Dec 05

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Nov 04

ICU Medical: Decisive M&A, Again

Sep 10

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Sep 05

業績と収益の成長予測

NasdaqGS:ICUI - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	2,386	82	188	271	2
12/31/2025	2,355	16	162	288	6
12/31/2024	2,269	-76	101	173	6
3/31/2024	2,257	-59	75	171	N/A
12/31/2023	2,259	-30	73	166	N/A
9/30/2023	2,249	-28	-13	73	N/A
6/30/2023	2,294	-48	-44	40	N/A
3/31/2023	2,306	-46	-110	-20	N/A
12/31/2022	2,280	-74	-161	-62	N/A
9/30/2022	2,043	-39	-78	22	N/A
6/30/2022	1,781	5	-1	99	N/A
3/31/2022	1,541	41	124	215	N/A
12/31/2021	1,316	103	186	268	N/A
9/30/2021	1,296	109	175	263	N/A
6/30/2021	1,279	103	168	260	N/A
3/31/2021	1,260	94	146	235	N/A
12/31/2020	1,271	87	122	223	N/A
9/30/2020	1,266	81	98	193	N/A
6/30/2020	1,255	83	73	168	N/A
3/31/2020	1,264	87	60	162	N/A
12/31/2019	1,266	101	-4	102	N/A
9/30/2019	1,291	73	3	103	N/A
6/30/2019	1,311	47	1	104	N/A
3/31/2019	1,359	55	57	160	N/A
12/31/2018	1,400	29	59	160	N/A
9/30/2018	1,430	86	90	195	N/A
6/30/2018	1,446	86	140	242	N/A
3/31/2018	1,417	18	119	210	N/A
12/31/2017	1,293	69	N/A	154	N/A
9/30/2017	1,018	28	N/A	91	N/A
6/30/2017	772	47	N/A	19	N/A
3/31/2017	537	101	N/A	-4	N/A
12/31/2016	379	63	N/A	90	N/A
9/30/2016	372	59	N/A	84	N/A
6/30/2016	361	56	N/A	77	N/A
3/31/2016	348	53	N/A	68	N/A
12/31/2015	340	45	N/A	64	N/A
9/30/2015	329	47	N/A	61	N/A
6/30/2015	321	37	N/A	61	N/A
3/31/2015	316	29	N/A	61	N/A
12/31/2014	307	26	N/A	66	N/A
9/30/2014	306	32	N/A	72	N/A
6/30/2014	311	37	N/A	69	N/A
3/31/2014	311	38	N/A	68	N/A
12/31/2013	312	40	N/A	66	N/A
9/30/2013	318	39	N/A	68	N/A
6/30/2013	317	41	N/A	61	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ICUIは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: ICUI今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: ICUI今後 3 年以内に収益を上げることが予想されます。

収益対市場: ICUIの収益 ( 2.5% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: ICUIの収益 ( 2.5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ICUIの自己資本利益率は、3年後には低くなると予測されています ( 4.7 %)。

ICU Medical 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Consensus EPS estimates fall by 65%

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Price target decreased by 24% to US$154

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

Consensus EPS estimates fall by 326%

Recent updates

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Chief Operating Officer recently sold US$1.3m worth of stock

Consensus EPS estimates fall by 65%

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

CEO & Chairman of the Board exercised options and sold US$262k worth of stock

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Director notifies of intention to sell stock

Chief Operating Officer recently sold US$1.5m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Chairman of the Board exercised options and sold US$5.4m worth of stock

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 24% to US$154

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Chief Operating Officer recently sold US$884k worth of stock

Chief Operating Officer notifies of intention to sell stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Now 23% undervalued after recent price drop

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

CEO & Chairman of the Board exercised options and sold US$3.9m worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Corporate VP notifies of intention to sell stock

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

CEO & Chairman of the Board exercised options and sold US$1.5m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Corporate VP notifies of intention to sell stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Director exercised options to buy US$12m worth of stock.

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Consensus EPS estimates fall by 326%

Price target decreased to US$221

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Consensus forecasts updated

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

ICU Medical, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Consensus EPS estimates fall by 18%

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 50%

Corporate VP recently sold US$130k worth of stock

Now 21% undervalued after recent price drop

First quarter 2022 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q1, 2022 Results on May 09, 2022

ICU Medical, Inc., Annual General Meeting, May 17, 2022

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

CEO & Chairman of the Board exercised options and sold US$411k worth of stock